1 Min Read
March 13 (Reuters) - Innate Pharma SA:
* Announces the expansion of Phase I/II trial evaluating lirilumab in combination with Opdivo Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.